i i
-
prohibitsmostroad ---, rllLIL~l buildingandloggingin national forestroadless areas. Rule, The covers 58.5 all mill&ra~~~sG~~~ --,__ inventoried national forestroadless areas. rule w~~~~ -The takeeffect March13,but has on nowbeendelayed theBush by ~--_-administra~o~-to~
undone. Passed 1996, Small in the Business Regulatory Enforcement Fairness - alsoknownasthe Act
Represen~~~~~S~nt~r~,-~~ President andurgethemto Bush
million publiccomments, over-
overturntheruleby a simple majority(51%) thePresident and mustsignit.
Pennsylvania Avenue, NW; Washington, 20500. DC
A 2000 announcement by theUS. Department Agriculture of thatit would stopbuyingmeat from downedcowsreflects the growingconsensus evenamong livestock industryandgovernment officials -that themarketing and slaughter downedanimals of is unacceptable. “Downed”refers animals to too sickor injuredevento stand:’I’ TheFarmSanctuary has petitioned U.S.Foodand.Drug the Administration (FDA)to prohibit theslaughter downedanimals. of Downedanimals arrivingat a slaughterhouse terrible suffer cruelty. Therearealsohealthrisks to humans. additionto possible In bacterial contamination, some downedanimals beafflicted may with a form of BSE (Bovine Spongiform Encephalopathy or
, :
“Mad CowDisease”), disease a whichhasbeenlinkedto a fatal humanillness(CJD Creutzfeldtor Jakob Disease). You can help, Please write the FDAandurgeit to grantpetition 9@-0151/ to prohibit-the Cl?1 slaughter downedanimals. of In your letter, additionto the in humanhealthdangers mention the foIlowing: l Animalstoo sickorinjuredeven to standshouldnotbeallowed to enterthehumanfoodchain. l Downedanimals typically are pushed tractors dragged with or with chains inhumane processes whichcause injuries rangingfrombruises and abrasions brokenbones to and torn ligaments. l Downedanimals comprise a verysmallpercentage animals of
-
slaughterec&and prohibiting theirmarketing cause will no undueeconr&ichardship. l Industryexperts estimated have that90% pesnt of downed animals can@prevented with bettercare&&handling. Removing marketfor t&s downed anin& will provide anincentiv&bindustryto prevent do&&d animals the in firstplace. Youmustreferto docket number98P-01511CPlyour in letter.Youmustsend your original letterandthreecopies theFDA. to Contact: US.FoodandDrugAdministration;Dockets Management Branch; Fishers 5630 Lane, Room 1061; Rockville, 20852; 301MD fax 827-6870; “fdadockets@ email
98P-0151
c Y3b(
c
nant,DNA Advisory x Committee theNational of titutesof Health.Sii-
available throughthe18member Secretary’s AdvisoryCommittee on Xenotrans-plantation, onwhichAPI ExecutiveDirectorAlan Bergerrepresents the animaladvocacy movement. “Thepublicmust knowwhat’sgoingon in theforefront medicine,” of said A proposed mikefromthe Alan.“Genetherapyand FoodandDrugAdministration (FDA)wouldprovidepublic xenotrans-plants potentially are access mostof thestudydesign to dangerous thatcanthreaten areas andsafety information all new on us all.” or ongoing clinicaltrialsinvolvYou can help, There a 90is pEil%c comment~doiith~ -mg eithergene therapy -- ---~~ XLtiJf or xenotransplantation. proposal. TheFDAwould not release In your comments, by due confidential business information April l&2001,point outthat: or personal information related to 0 Thisproposal bringsgene only therapyandxenotransplantastudyparticipants. tion in compliance the with In humangene therapy, the biological properties living /: of same typesof information cellsarealtered therapeutic; for already released thepublic to use.Xenotransplantation is the.; by othergovernment agencies. transfer organs ananimal of from Because .grave of publichealth ‘T, risks,disclosure shouldinclude to a human. Muchof theinformation th& -additional information as such wouldbedisclosed aboutgene physicians, medical centers, and therapy trialsunderthisproposal soon- makepublicall information except tradesecrets is already publiclydiscussed in andpatientidentification. .open meetings theRecombiof
TheFDAmustassume the.sole responsibilityfor summarizing anddistributing information submitted theresearch by sponsor, ratherthanleave to it thes~onsor’s discretion. * Because thepublichealth of risks,ethical issues, cost uncertainty theinabilityto and adequately assess other alternatives, all xenotransplantation clinical trialsshouldstop. , Youmustreferto docket numberOON-0989your letter. in Youmustsendyour originalietter andthreecopies theFDA. to Contact: U.S.FoodandDrugAdministration;Dockets Management Branch; Fishers 5630 Lane; Room 1061; HFA-305; Rockvine, MD 20852; 301-827-6870; fax email ---“fZidocket~~a.gov”;
l
I I ; / i I
ANIMAL I’RiDTECTION #NSTlTUTE Mailing Addtisk ’
PO. 8Ok 22505
Socramenfo, 95822 CA Sir+ Address: 2831Fruifridge Rood sacnmenfo, CA95820, Ph. 916.731.5521 Fx.916.731.4467 wwwopi4animals.org info@api4onimols.org
Recycled Paper/Soy Inks /Recyclable